期刊文献+

药物洗脱支架在急性ST段抬高型心肌梗死患者介入术后血栓形成的相关因素分析 被引量:8

Analysis of the related factors of drug-eluting stent thrombosis after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
原文传递
导出
摘要 目的:探讨ST段抬高性心肌梗死患者经皮冠状动脉介入置入雷帕霉素药物洗脱支架内血栓形成的相关因素及预后。方法:845例ST段抬高型心肌梗死患者行直接经皮冠状动脉介入置入雷帕霉素药物洗脱支架,随访6个月,分析21例发生血栓形成的相关因素及预后。结果:血栓形成发生率2.49%,血栓形成组与无血栓形成组在年龄、糖尿病、左室射血分数、停用氯吡格雷、6个月病死率、再次靶血管重建率及再次靶病变重建率等方面差异有统计学意义(P<0.05)。多因素分析显示糖尿病史、左室射血分数、停用抗血小板药物、前降支病变、支架直径、数量及长度是血栓形成的独立影响因素。结论:雷帕霉素药物洗脱支架血栓形成是多因素相关的临床事件,患者病死率高,预后差,应引起高度重视。 Objective To study the related factors and prognosis of rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Methods Percutaneous coronary intervention was performed in 845 patients with ST- segment elevation myocardial infarction which were implanted rapamycin drug-eluting stent. All the patient were followed up for 6 months. Stent thrombosis occurred in 21 patients and the related factors and prognosis were analyzed. Results The incidence of stent thrombosis was 2. 49%. Stent thrombosis was associated with an increased risk of stent thrombosis, including age, diabetes, left ventricular eject fraction, premature cessation of clopidogrel, the mortality, re-TVR and re-TLR at 6 months(P〈0. 05). Multivariate analysis showed that the age, diabetes, left ventricular eject fraction, cessation of clopidogrel, diameter, number and length of stent were independent risk factors of stent thrombosis. Conclusion Rapamycin drug-eluting stent thrombosis is a clinical event of multiple factor with high fatality and poor clinical prognosis, and should be paid much attention.
出处 《中华实用诊断与治疗杂志》 2009年第6期557-559,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 心肌梗死 冠状动脉介入 药物洗脱支架 支架内血栓形成 Myocardial infarction percutaneous coronary intervention drug-eluting stent stent thrombosis
  • 相关文献

参考文献10

  • 1中华医学会心血管病学分会.中华心血管病杂志编辑委员会、中国循环杂志编辑委员会、急性ST段抬高心梗诊断和治疗指南.中华心血管病杂志,2001,29(12):710-725.
  • 2Cutlip D E, W indecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions[J]. Circulation, 2007,115(17) :2344 -2351.
  • 3Thomas F L, Jan S, Franz R, et al. Drug eluting stent and coronary thrombosis[J]. Circulation, 2007,115 (3) : 1051- 1058.
  • 4潘静薇,魏盟,李京波,陆志刚,马士新,魏钧伯.急性心肌梗死患者住院期死亡相关因素变化分析[J].实用诊断与治疗杂志,2007,21(4):280-282. 被引量:8
  • 5Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement Srom the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabnlism[J]. Circulation, 2008,117(12) :1610- 1619.
  • 6Duk-Woo P, Seong Wook P, Kyoung-Ha P, et al. Frequency of/ and risk factors for stent thrombosis after drug eluting stem implantation during long term follow-up[J]. Am J Cardiol, 2006, 98 (3) : 352-356.
  • 7Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eluting stents[J]. JAMA,2005,293(17) :2126 -3210.
  • 8Cheneau E , Leborgne L , Mintz G S, et al. Predictors of subacute stent thrombosis: results of asystematic intravascular ultrasound study[J]. Circulation, 2003,108 (1) : 43-47.
  • 9Windecker S, Remondino A, Eberli F R, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization[J]. N Engl J Med,2005,353(7) :653-662.
  • 10陈劢,卢辉,茶春喜,姚建平,杜晓强,艾克拜尔.Firebird冠状动脉内支架的临床应用[J].实用诊断与治疗杂志,2007,21(8):609-610. 被引量:4

二级参考文献16

  • 1潘静薇,郑兴,丁继军,秦永文,陈凌,何亚.急性心肌梗死患者相关因素变化分析[J].中华心血管病杂志,2005,33(3):215-215. 被引量:8
  • 2郭雷静,弭淑梅,司正英.心肌梗死急性期血糖的变化特点及其原因判定价值的研究[J].实用诊断与治疗杂志,2006,20(6):451-452. 被引量:2
  • 3Tespili M,Guagliumi G,Valsecchi O,et al.In-hospital clinical outcome in elderly patients with acute myocardial infarction treated with primary angioplasty[J ].Ital Heart J,2003,4 (3):193-198.
  • 4Kuwahara E,Otsuji Y,Takasaki K,et al.Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction[J].Circ J,2006,70(3):217-221.
  • 5Srihari S,Naidu M D,Faith Selzer PhD,et al.Renal insufficiency is an independent redictor of mortality after percutaneous coronary intervention[J].Am J Cardiol,2003,92(10):1160-1164.
  • 6Singh R B,Pella D,Sharma J P,et al.Inflammation,insulin resistance,and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus[J].J Clin Endocrinol Metab,2005,90(1):175-180.
  • 7Ascione L,De Michele M,Accadia M,et al.Myocardial global performance index as a predictor of adverse events in patients with first myocardial infarction[ J].J Am Soc Echocardiogr,2003,16 (10):1019-1023.
  • 8Popescu B A,Antonini Canterin F,Temporelli P L,et al.Right ventricular functional recovery after acute myocardial infarction:relation with left ventricular function and interventricular septum motion.GISSI-3 echo substudy[J ].Heart,2005,91 (4):484-488.
  • 9Janardhanan R,Moon J C,Pennell D J,et al.Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction[J].Am Heart J,2005,149(2):355-362.
  • 10Thune J J,Carlsen C,Buch P,et al.Different prognostic impact of systolic function in patients with heart failure and/or acute myocardial infarction[J].Eur J Heart Fail,2005,7 (5):852-858.

共引文献10

同被引文献48

  • 1郝盼盼,陈玉国,张运.氯吡格雷抵抗相关因素的研究进展[J].心血管病学进展,2009,30(6):991-994. 被引量:21
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2113
  • 3赵福海,吕树铮,陈韵岱.冠状动脉分叉病变的当代治疗现状[J].中国介入心脏病学杂志,2007,15(3):175-177. 被引量:2
  • 4Wang Z J, Zhou Y J, I.iu Y Y, el al. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent[J]. Thromb Res, 2009,124 (1) :46-51.
  • 5Muller I, Besta F, Schulz C, et al. Prevalence of elopidogrel non responders among patients with stable angina peetoris scheduled for elective coronary stent placement[J]. Thrombo Haemost, 2003,89 (5) : 783-787.
  • 6Gurbel P A, Bliden K P, Hiatt B L, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity[J]. Circulation, 2003, 107(23) :2908 2913.
  • 7Serebruany V L, Steinhubl S R, Berger P B, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals[J]. J Am Coll Cardiol,2005,45(2)..246-251.
  • 8Barragan P, Bouvier J L, Roquebert P O, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation[J].Cat heter Cardiovasc Interv, 2003, 59 (3) 295-302.
  • 9Snoep J D, Hovens M M, Eikenboom J C, et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and metaanalysis[J].Am Heart J,2007, I54(2) : 221-231.
  • 10Cutlip D E, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions[J]. Circulation,2007,115(17) : 2344-2351.

引证文献8

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部